122 related articles for article (PubMed ID: 38104669)
21. Gene-specific selection against experimental fanconi anemia gene inactivation in human cancer.
Gallmeier E; Hucl T; Calhoun ES; Cunningham SC; Bunz F; Brody JR; Kern SE
Cancer Biol Ther; 2007 May; 6(5):654-60. PubMed ID: 17387268
[TBL] [Abstract][Full Text] [Related]
22. Proteasome function is required for DNA damage response and fanconi anemia pathway activation.
Jacquemont C; Taniguchi T
Cancer Res; 2007 Aug; 67(15):7395-405. PubMed ID: 17671210
[TBL] [Abstract][Full Text] [Related]
23. FANCD2 monoubiquitination provides a link between the HHR6 and FA-BRCA pathways.
Zhang J; Zhao D; Wang H; Lin CJ; Fei P
Cell Cycle; 2008 Feb; 7(3):407-13. PubMed ID: 18277096
[TBL] [Abstract][Full Text] [Related]
24. The RPA inhibitor HAMNO sensitizes Fanconi anemia pathway-deficient cells.
Jang SW; Kim JM
Cell Cycle; 2022 Jul; 21(14):1468-1478. PubMed ID: 35506981
[TBL] [Abstract][Full Text] [Related]
25. Conserved function of Drosophila Fancd2 monoubiquitination in response to double-strand DNA breaks.
Clay DE; Jezuit EA; Montague RA; Fox DT
G3 (Bethesda); 2022 Jul; 12(8):. PubMed ID: 35595243
[TBL] [Abstract][Full Text] [Related]
26. Overlooked FANCD2 variant encodes a promising, portent tumor suppressor, and alternative polyadenylation contributes to its expression.
Han B; Shen Y; Zhang P; Jayabal P; Che R; Zhang J; Yu H; Fei P
Oncotarget; 2017 Apr; 8(14):22490-22500. PubMed ID: 28157704
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive analysis of the autophagy-dependent ferroptosis-related gene FANCD2 in lung adenocarcinoma.
Miao H; Ren Q; Li H; Zeng M; Chen D; Xu C; Chen Y; Wen Z
BMC Cancer; 2022 Mar; 22(1):225. PubMed ID: 35236309
[TBL] [Abstract][Full Text] [Related]
28. Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype.
Kalb R; Neveling K; Hoehn H; Schneider H; Linka Y; Batish SD; Hunt C; Berwick M; Callen E; Surralles J; Casado JA; Bueren J; Dasi A; Soulier J; Gluckman E; Zwaan CM; van Spaendonk R; Pals G; de Winter JP; Joenje H; Grompe M; Auerbach AD; Hanenberg H; Schindler D
Am J Hum Genet; 2007 May; 80(5):895-910. PubMed ID: 17436244
[TBL] [Abstract][Full Text] [Related]
29. Defective FANCI binding by a fanconi anemia-related FANCD2 mutant.
Sato K; Ishiai M; Takata M; Kurumizaka H
PLoS One; 2014; 9(12):e114752. PubMed ID: 25489943
[TBL] [Abstract][Full Text] [Related]
30. FANCD2 limits acetaldehyde-induced genomic instability during DNA replication in esophageal keratinocytes.
Peake JD; Noguchi C; Lin B; Theriault A; O'Connor M; Sheth S; Tanaka K; Nakagawa H; Noguchi E
Mol Oncol; 2021 Nov; 15(11):3109-3124. PubMed ID: 34328261
[TBL] [Abstract][Full Text] [Related]
31. FANCD2 monoubiquitination and activation by hexavalent chromium [Cr(VI)] exposure: activation is not required for repair of Cr(VI)-induced DSBs.
Vilcheck SK; Ceryak S; O'Brien TJ; Patierno SR
Mutat Res; 2006 Nov; 610(1-2):21-30. PubMed ID: 16893675
[TBL] [Abstract][Full Text] [Related]
32. Heterozygosity for p53 (Trp53+/-) accelerates epithelial tumor formation in fanconi anemia complementation group D2 (Fancd2) knockout mice.
Houghtaling S; Granville L; Akkari Y; Torimaru Y; Olson S; Finegold M; Grompe M
Cancer Res; 2005 Jan; 65(1):85-91. PubMed ID: 15665282
[TBL] [Abstract][Full Text] [Related]
33. BLM promotes the activation of Fanconi Anemia signaling pathway.
Panneerselvam J; Wang H; Zhang J; Che R; Yu H; Fei P
Oncotarget; 2016 May; 7(22):32351-61. PubMed ID: 27083049
[TBL] [Abstract][Full Text] [Related]
34. Arsenic exposure disrupts the normal function of the FA/BRCA repair pathway.
Peremartí J; Ramos F; Marcos R; Hernández A
Toxicol Sci; 2014 Nov; 142(1):93-104. PubMed ID: 25092648
[TBL] [Abstract][Full Text] [Related]
35. Assessment of FANCD2 nuclear foci formation in paraffin-embedded tumors: a potential patient-enrichment strategy for treatment with DNA interstrand crosslinking agents.
Duan W; Gao L; Zhao W; Leon M; Sadee W; Webb A; Resnick K; Wu X; Ramaswamy B; Cohn DE; Shapiro C; Andreassen PR; Otterson GA; Villalona-Calero MA
Transl Res; 2013 Mar; 161(3):156-64. PubMed ID: 23063585
[TBL] [Abstract][Full Text] [Related]
36. Cells Deficient in the Fanconi Anemia Protein FANCD2 are Hypersensitive to the Cytotoxicity and DNA Damage Induced by Coffee and Caffeic Acid.
Burgos-Morón E; Calderón-Montaño JM; Orta ML; Guillén-Mancina E; Mateos S; López-Lázaro M
Toxins (Basel); 2016 Jul; 8(7):. PubMed ID: 27399778
[TBL] [Abstract][Full Text] [Related]
37. Advances in the understanding of the Fanconi anemia tumor suppressor pathway.
Pickering A; Zhang J; Panneerselvam J; Fei P
Cancer Biol Ther; 2013 Dec; 14(12):1089-91. PubMed ID: 24025411
[TBL] [Abstract][Full Text] [Related]
38. Silencing of FANCI Promotes DNA Damage and Sensitizes Ovarian Cancer Cells to Carboplatin.
Li Y; Zhang Y; Yang Q; Zhou X; Guo Y; Ding F; Liu Z; Luo A
Curr Cancer Drug Targets; 2022; 22(7):591-602. PubMed ID: 35362384
[TBL] [Abstract][Full Text] [Related]
39. CtIP mediates replication fork recovery in a FANCD2-regulated manner.
Yeo JE; Lee EH; Hendrickson EA; Sobeck A
Hum Mol Genet; 2014 Jul; 23(14):3695-705. PubMed ID: 24556218
[TBL] [Abstract][Full Text] [Related]
40. Regulation of the activation of the Fanconi anemia pathway by the p21 cyclin-dependent kinase inhibitor.
Rego MA; Harney JA; Mauro M; Shen M; Howlett NG
Oncogene; 2012 Jan; 31(3):366-75. PubMed ID: 21685936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
